MRC1 and breast cancer: A 99mTc-labeled nanobody targeting the Macrophage Mannose Receptor (MMR, or CD206), which is highly expressed by the immunosuppressive M2-like macrophages, has been utilized for SPECT imaging in preclinical models of lung and mammary tumors.